Life Science Investing Axsome Therapeutics to Participate in Upcoming Investor Conferences 20 November
Life Science Investing Axsome Therapeutics Acquires Subtype Selective GABA-A Receptor Positive Allosteric Modulator AZD7325 for the Treatment of Epilepsy 06 November
Life Science Investing Avenue Therapeutics Announces Acquisition of Subsidiary Baergic Bio by Axsome Therapeutics 06 November
